Dexcom (DXCM) Current Leases (2019 - 2026)

Dexcom (DXCM) has 8 years of Current Leases data on file, last reported at $20.5 million in Q1 2026.

• On a quarterly basis, Current Leases fell 9.29% year-over-year to $20.5 million in Q1 2026; TTM through Mar 2026 was $20.5 million, a 9.29% decrease from a year earlier, with the FY2025 full-year figure at $21.6 million, down 4.0% from the prior year.
• Current Leases for Q1 2026 stood at $20.5 million, down from $21.6 million in the prior quarter.
• Over the last five years, Current Leases for DXCM reached as high as $23.6 million in Q3 2025 and fell as low as $20.5 million in Q4 2022.
• Historically, Current Leases has averaged $21.7 million across 5 years, with a median of $21.6 million in 2024.
• Across the five-year window, Current Leases gained 14.84% in 2022 and declined 9.29% in 2026, its largest moves.
• Year by year, Current Leases stood at $20.5 million in 2022, then increased by 2.93% to $21.1 million in 2023, then increased by 6.64% to $22.5 million in 2024, then decreased by 4.0% to $21.6 million in 2025, then slipped by 5.09% to $20.5 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $20.5 million in Q1 2026, $21.6 million in Q4 2025, and $23.6 million in Q3 2025.